573 related articles for article (PubMed ID: 11526908)
21. Lateral recognition of a dye hapten by a llama VHH domain.
Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C
J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862
[TBL] [Abstract][Full Text] [Related]
22. A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire.
Deschacht N; De Groeve K; Vincke C; Raes G; De Baetselier P; Muyldermans S
J Immunol; 2010 May; 184(10):5696-704. PubMed ID: 20404276
[TBL] [Abstract][Full Text] [Related]
23. Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain Antibodies.
Li X; Duan X; Yang K; Zhang W; Zhang C; Fu L; Ren Z; Wang C; Wu J; Lu R; Ye Y; He M; Nie C; Yang N; Wang J; Yang H; Liu X; Tan W
PLoS One; 2016; 11(9):e0161801. PubMed ID: 27588755
[TBL] [Abstract][Full Text] [Related]
24. Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains.
Muyldermans S; Cambillau C; Wyns L
Trends Biochem Sci; 2001 Apr; 26(4):230-5. PubMed ID: 11295555
[TBL] [Abstract][Full Text] [Related]
25. Naturally occurring antibodies devoid of light chains.
Hamers-Casterman C; Atarhouch T; Muyldermans S; Robinson G; Hamers C; Songa EB; Bendahman N; Hamers R
Nature; 1993 Jun; 363(6428):446-8. PubMed ID: 8502296
[TBL] [Abstract][Full Text] [Related]
26. Affinity transfer to a human protein by CDR3 grafting of camelid VHH.
Inoue H; Iihara A; Takahashi H; Shimada I; Ishida I; Maeda Y
Protein Sci; 2011 Dec; 20(12):1971-81. PubMed ID: 21910150
[TBL] [Abstract][Full Text] [Related]
27. Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability.
Davies J; Riechmann L
Protein Eng; 1996 Jun; 9(6):531-7. PubMed ID: 8862554
[TBL] [Abstract][Full Text] [Related]
28. Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen.
Saerens D; Kinne J; Bosmans E; Wernery U; Muyldermans S; Conrath K
J Biol Chem; 2004 Dec; 279(50):51965-72. PubMed ID: 15459193
[TBL] [Abstract][Full Text] [Related]
29. Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama.
Renisio JG; Pérez J; Czisch M; Guenneugues M; Bornet O; Frenken L; Cambillau C; Darbon H
Proteins; 2002 Jun; 47(4):546-55. PubMed ID: 12001233
[TBL] [Abstract][Full Text] [Related]
30. A single-step procedure of recombinant library construction for the selection of efficiently produced llama VH binders directed against cancer markers.
Kastelic D; Frković-Grazio S; Baty D; Truan G; Komel R; Pompon D
J Immunol Methods; 2009 Oct; 350(1-2):54-62. PubMed ID: 19744487
[TBL] [Abstract][Full Text] [Related]
31. An anti-hapten camelid antibody reveals a cryptic binding site with significant energetic contributions from a nonhypervariable loop.
Fanning SW; Horn JR
Protein Sci; 2011 Jul; 20(7):1196-207. PubMed ID: 21557375
[TBL] [Abstract][Full Text] [Related]
32. Studies of thermostability in Camelus bactrianus (Bactrian camel) single-domain antibody specific for the mutant epidermal-growth-factor receptor expressed by Pichia.
Omidfar K; Rasaee MJ; Kashanian S; Paknejad M; Bathaie Z
Biotechnol Appl Biochem; 2007 Jan; 46(Pt 1):41-9. PubMed ID: 16848761
[TBL] [Abstract][Full Text] [Related]
33. Comparison of llama VH sequences from conventional and heavy chain antibodies.
Vu KB; Ghahroudi MA; Wyns L; Muyldermans S
Mol Immunol; 1997; 34(16-17):1121-31. PubMed ID: 9566760
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.
De Genst E; Silence K; Decanniere K; Conrath K; Loris R; Kinne J; Muyldermans S; Wyns L
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4586-91. PubMed ID: 16537393
[TBL] [Abstract][Full Text] [Related]
35. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
36. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies.
Lauwereys M; Arbabi Ghahroudi M; Desmyter A; Kinne J; Hölzer W; De Genst E; Wyns L; Muyldermans S
EMBO J; 1998 Jul; 17(13):3512-20. PubMed ID: 9649422
[TBL] [Abstract][Full Text] [Related]
37. Systematic Engineering of Optimized Autonomous Heavy-Chain Variable Domains.
Nilvebrant J; Ereño-Orbea J; Gorelik M; Julian MC; Tessier PM; Julien JP; Sidhu SS
J Mol Biol; 2021 Oct; 433(21):167241. PubMed ID: 34508727
[TBL] [Abstract][Full Text] [Related]
38. Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure.
Spinelli S; Desmyter A; Frenken L; Verrips T; Tegoni M; Cambillau C
FEBS Lett; 2004 Apr; 564(1-2):35-40. PubMed ID: 15094039
[TBL] [Abstract][Full Text] [Related]
39. Efficient tumor targeting by single-domain antibody fragments of camels.
Cortez-Retamozo V; Lauwereys M; Hassanzadeh Gh G; Gobert M; Conrath K; Muyldermans S; De Baetselier P; Revets H
Int J Cancer; 2002 Mar; 98(3):456-62. PubMed ID: 11920600
[TBL] [Abstract][Full Text] [Related]
40. A Two-Step Approach for the Design and Generation of Nanobodies.
Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
